Alnylam Pharmaceuticals, Inc. — US02043QAD97
Source record · Alnylam Pharmaceuticals, Inc. — US02043QAD97
- ISIN
- US02043QAD97
- Issuer LEI
- 529900S3ZI14OWRJII50
- Issuer
- Alnylam Pharmaceuticals, Inc.
- Prefix
- US
- Country
- United States
- National code
- 02043QAD9
- Check digit
- 7 (verifies)
- CUSIP
- 02043QAD9
- Handle
- #://US02043QAD97
- Edition address
- web+usd://isin-us02043qad97
- GTIN
- 29071934710636
Source · https://mapping.gleif.org/api/v2/isin-lei?page%5Bnumber%5D=1&page%5Bsize%5D=1
Retrieved · 2026-10-18T05:47:01.182Z
ISIN US02043QAD97 edition: identity from GLEIF/ANNA (CC0); no valuation or affiliation implied. CUSIP 02043QAD9 is derived from the ISIN itself.